KPTI

Karyopharm Therapeutics Inc

• Benzinga·19h ago

  12 Health Care Stocks Moving In Monday's After-Market Session

• Benzinga·5d ago

  12 Health Care Stocks Moving In Wednesday's Intraday Session

• Benzinga·6d ago

  Karyopharm Therapeutics Extends Forbearance Period To October 15

• Benzinga·10/05 17:05

  12 Health Care Stocks Moving In Monday's Intraday Session

• TipRanks·09/18 20:36

  Karyopharm Issues Convertible Preferred Stock, Alters Capital Structure

• TipRanks·09/11 12:18

  Karyopharm Faces Liquidity Crisis Under Forbearance Agreement

• Benzinga·09/11 12:06

  12 Health Care Stocks Moving In Friday's Pre-Market Session

• TipRanks·09/11 11:55

  Karyopharm, guarantors enter into forbearance agreement

• Benzinga·09/11 11:51

  Karyopharm Therapeutics Signs Forbearance Agreement, Limited Waiver To Indentures For Additional Time To Advance Its Myelofibrosis Program; Did Not Pay $15.8M Due Under Sept. 10 Credit Agreement

• Seeking Alpha·09/02 14:15

  Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in Aug 2026

• TipRanks·09/01 12:50

  Analysts Offer Insights on Healthcare Companies: IDEAYA Biosciences (IDYA), BioMarin Pharmaceutical (BMRN) and Karyopharm Therapeutics (KPTI)

• NASDAQ·08/31 13:06

  Karyopharm Submits SNDA For XPOVIO Plus Ruxolitinib In Myelofibrosis; Stock Up

• TipRanks·08/31 12:28

  Karyopharm Seeks Accelerated FDA Approval for XPOVIO Combo

• NASDAQ·08/31 11:52

  Karyopharm Submits SNDA Seeking Accelerated Approval For XPOVIO In Combination With Ruxolitinib

• Benzinga·08/31 11:32

  Karyopharm Therapeutics Submits sNDA To FDA Seeking Accelerated Approval For XPOVIO In Combination With Ruxolitinib For Patients With Myelofibrosis